Skip to main content
2025 Scottsdale Headache Symposium Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded
Recorded
SIG
SIG

Session: *Industry Symposium: Data-Driven Decisions in Migraine Prevention: Unpacking Recent Head-to-Head Trial Results

Industry Symposium: Data-Driven Decisions in Migraine Prevention: Unpacking Recent Head-to-Head Trial Results *

Friday, December 5, 2025
7:00 AM - 8:00 AM MST
Location: Kierland Grand Ballroom 1ABC
This symposium will discuss:
1. Review pivotal clinical data from a CGRP antagonist, QULIPTA, including recent head-to-head trial results against the most prescribed non-migraine specific preventive medication in the treatment landscape.
2. Discuss considerations in medication effectiveness and selection like efficacy, safety, tolerability, and access.
3. Facilitate discussion on optimizing treatment choices and real-world clinical decision making by way of interactive patient cases.

Sponsored by Abbvie

Learning Objectives:

  • Upon completion participants will have learnt about blinded head to head study design
  • Upon completion participants will have learnt about the results between commonly used migraine preventive treatments in a controlled setting
  • Upon completion participants will have learnt about the value of effectiveness compared to efficacy alone as an outcome measure when comparing between different migraine preventive medications.